Michael J. Pederson
Corporate Officer/Principal at Abbott Ltd.
Net worth: 7 M $ as of 2024-04-29
Profile
Michael J.
Pederson is currently working as a Finance Manager-Licensing & Acquisitions at Abbott Ltd.
Prior to this, he worked as the Chief Executive Officer at Vytronus, Inc. and as an Independent Director at EPIX Therapeutics, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ABBOTT LABORATORIES
0.00% | 2023-02-27 | 63,231 ( 0.00% ) | 7 M $ | 2024-04-29 |
Michael J. Pederson active positions
| Companies | Position | Start |
|---|---|---|
| Abbott Ltd. | Corporate Officer/Principal | - |
Former positions of Michael J. Pederson
| Companies | Position | End |
|---|---|---|
Vytronus, Inc.
 Vytronus, Inc. Medical SpecialtiesHealth Technology VytronUS, Inc. develops imaging and therapeutic capabilities of ultrasound energy to treat cardiac arrhythmias. The firm develops a catheter-based ablation platform based on low-intensity collimated ultrasound (LICU) which allows for precise non-contact energy delivery and producing high-resolution maps of cardiac anatomy. The company was founded by Hira V. Thapliyal in 2006 and is headquartered in Sunnyvale, CA. | Chief Executive Officer | 2015-04-05 |
EPIX Therapeutics, Inc.
 EPIX Therapeutics, Inc. Electronic Equipment/InstrumentsElectronic Technology EPIX Therapeutics, Inc. operates as a medical device company that designs and manufactures catheter-based systems. It offers irrigated radiofrequency ablation catheters for atrial fibrillation. The company was founded by Kenneth Carr, Peter van der Sluis, Eric Kanowsky and Timothy J. Lenihan in 2007 and is headquartered in Santa Clara, CA. | Director/Board Member | - |
Experiences
Positions held
Linked companies
| Private companies | 3 |
|---|---|
Vytronus, Inc.
Vytronus, Inc. Medical SpecialtiesHealth Technology VytronUS, Inc. develops imaging and therapeutic capabilities of ultrasound energy to treat cardiac arrhythmias. The firm develops a catheter-based ablation platform based on low-intensity collimated ultrasound (LICU) which allows for precise non-contact energy delivery and producing high-resolution maps of cardiac anatomy. The company was founded by Hira V. Thapliyal in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
EPIX Therapeutics, Inc.
EPIX Therapeutics, Inc. Electronic Equipment/InstrumentsElectronic Technology EPIX Therapeutics, Inc. operates as a medical device company that designs and manufactures catheter-based systems. It offers irrigated radiofrequency ablation catheters for atrial fibrillation. The company was founded by Kenneth Carr, Peter van der Sluis, Eric Kanowsky and Timothy J. Lenihan in 2007 and is headquartered in Santa Clara, CA. | Electronic Technology |
| Abbott Ltd. |
- Stock Market
- Insiders
- Michael J. Pederson
